Universal Biosensors, Inc. (UBI.AX)
AUD 0.06
(-1.54%)
AUD 0.06
(-1.54%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.37 Million AUD | 39.33% |
| 2022 | 3.14 Million AUD | 46.59% |
| 2021 | 2.14 Million AUD | 14.03% |
| 2020 | 1.87 Million AUD | 74.37% |
| 2019 | 1.07 Million AUD | 44.81% |
| 2018 | 744.46 Thousand AUD | 12.43% |
| 2017 | 662.13 Thousand AUD | -21.1% |
| 2016 | 839.25 Thousand AUD | 136.23% |
| 2015 | 355.26 Thousand AUD | -10.61% |
| 2014 | 397.45 Thousand AUD | 9347.35% |
| 2013 | 4207.00 AUD | -99.88% |
| 2012 | 3.6 Million AUD | -0.47% |
| 2011 | 3.61 Million AUD | 13.42% |
| 2010 | 3.19 Million AUD | 945.83% |
| 2009 | 305.12 Thousand AUD | -91.82% |
| 2008 | 3.73 Million AUD | 662.41% |
| 2007 | 489.27 Thousand AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 5.5 Million AUD | 0.95% |
| 2024 Q1 | 5.38 Million AUD | 22.96% |
| 2024 Q2 | 5.45 Million AUD | 1.31% |
| 2023 Q1 | 2.98 Million AUD | -4.98% |
| 2023 Q4 | 4.37 Million AUD | 16.97% |
| 2023 FY | 4.37 Million AUD | 39.33% |
| 2023 Q2 | 3.7 Million AUD | 24.15% |
| 2023 Q3 | 3.74 Million AUD | 0.98% |
| 2022 Q2 | 2.39 Million AUD | -0.7% |
| 2022 FY | 3.14 Million AUD | 46.59% |
| 2022 Q1 | 2.4 Million AUD | 12.33% |
| 2022 Q3 | 4.16 Million AUD | 73.99% |
| 2022 Q4 | 3.14 Million AUD | -24.47% |
| 2021 FY | 2.14 Million AUD | 14.03% |
| 2021 Q4 | 2.14 Million AUD | 4.88% |
| 2021 Q1 | 1.69 Million AUD | -9.68% |
| 2021 Q2 | 1.48 Million AUD | -12.72% |
| 2021 Q3 | 2.04 Million AUD | 37.92% |
| 2020 Q4 | 1.87 Million AUD | -7.56% |
| 2020 Q1 | 986.29 Thousand AUD | -8.51% |
| 2020 Q2 | 614.26 Thousand AUD | -37.72% |
| 2020 FY | 1.87 Million AUD | 74.37% |
| 2020 Q3 | 2.03 Million AUD | 231.05% |
| 2019 Q3 | 1.25 Million AUD | 30.43% |
| 2019 FY | 1.07 Million AUD | 44.81% |
| 2019 Q2 | 964.31 Thousand AUD | 6.06% |
| 2019 Q1 | 909.19 Thousand AUD | 22.13% |
| 2019 Q4 | 1.07 Million AUD | -14.28% |
| 2018 Q4 | 744.46 Thousand AUD | 54.68% |
| 2018 Q1 | 881.88 Thousand AUD | 33.19% |
| 2018 FY | 744.46 Thousand AUD | 12.43% |
| 2018 Q2 | 639.17 Thousand AUD | -27.52% |
| 2018 Q3 | 481.28 Thousand AUD | -24.7% |
| 2017 Q2 | 1.19 Million AUD | 26.92% |
| 2017 Q3 | 642.26 Thousand AUD | -46.08% |
| 2017 Q4 | 662.13 Thousand AUD | 3.09% |
| 2017 FY | 662.13 Thousand AUD | -21.1% |
| 2017 Q1 | 938.57 Thousand AUD | 11.83% |
| 2016 Q1 | 291.94 Thousand AUD | -17.83% |
| 2016 FY | 839.25 Thousand AUD | 136.23% |
| 2016 Q4 | 839.25 Thousand AUD | 49.33% |
| 2016 Q3 | 562 Thousand AUD | 112.81% |
| 2016 Q2 | 264.08 Thousand AUD | -9.54% |
| 2015 Q2 | 656.61 Thousand AUD | 9.69% |
| 2015 Q3 | 538.77 Thousand AUD | -17.95% |
| 2015 Q1 | 598.57 Thousand AUD | 50.6% |
| 2015 Q4 | 355.26 Thousand AUD | -34.06% |
| 2015 FY | 355.26 Thousand AUD | -10.61% |
| 2014 FY | 397.45 Thousand AUD | 9347.35% |
| 2014 Q3 | 393.74 Thousand AUD | 50.36% |
| 2014 Q1 | 1.12 Million AUD | 26693.77% |
| 2014 Q4 | 397.45 Thousand AUD | 0.94% |
| 2014 Q2 | 261.87 Thousand AUD | -76.77% |
| 2013 Q4 | 4207.00 AUD | -99.82% |
| 2013 Q2 | 2.25 Million AUD | -36.17% |
| 2013 Q1 | 3.52 Million AUD | -2.02% |
| 2013 FY | 4207.00 AUD | -99.88% |
| 2013 Q3 | 2.38 Million AUD | 5.81% |
| 2012 Q4 | 3.6 Million AUD | 18.61% |
| 2012 Q3 | 3.03 Million AUD | 26.25% |
| 2012 Q2 | 2.4 Million AUD | 0.0% |
| 2012 FY | 3.6 Million AUD | -0.47% |
| 2011 Q3 | 3.07 Million AUD | -5.01% |
| 2011 Q2 | 3.23 Million AUD | 0.0% |
| 2011 Q4 | 3.61 Million AUD | 17.72% |
| 2011 FY | 3.61 Million AUD | 13.42% |
| 2010 Q4 | 3.19 Million AUD | 118.75% |
| 2010 Q3 | 1.45 Million AUD | 94.19% |
| 2010 FY | 3.19 Million AUD | 945.83% |
| 2010 Q2 | 751.2 Thousand AUD | 0.0% |
| 2009 Q2 | - AUD | 0.0% |
| 2009 FY | 305.12 Thousand AUD | -91.82% |
| 2009 Q4 | 305.12 Thousand AUD | 0.0% |
| 2008 FY | 3.73 Million AUD | 662.41% |
| 2008 Q4 | 3.73 Million AUD | 0.0% |
| 2008 Q2 | 707.02 Thousand AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| 2007 FY | 489.27 Thousand AUD | 0.0% |
| 2007 Q4 | 429.01 Thousand AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| 4DMedical Limited | 992.24 Thousand AUD | -341.213% |
| Adherium Limited | 1.58 Million AUD | -176.682% |
| Aroa Biosurgery Limited | 7.43 Million AUD | 41.079% |
| Atomo Diagnostics Limited | 1.83 Million AUD | -138.092% |
| Anteris Technologies Ltd | 646.71 Thousand AUD | -576.951% |
| Control Bionics Limited | 404.15 Thousand AUD | -983.245% |
| CardieX Limited | 2.55 Million AUD | -71.448% |
| Compumedics Limited | 13.21 Million AUD | 66.861% |
| Cochlear Limited | 391.6 Million AUD | 98.882% |
| CleanSpace Holdings Limited | 2.86 Million AUD | -52.781% |
| Cyclopharm Limited | 10.12 Million AUD | 56.748% |
| EMVision Medical Devices Ltd | - AUD | -Infinity% |
| Nova Eye Medical Limited | 4.28 Million AUD | -2.217% |
| HeraMED Limited | 361.61 Thousand AUD | -1110.671% |
| Imricor Medical Systems, Inc. | 2.46 Million AUD | -77.671% |
| ImpediMed Limited | 759 Thousand AUD | -476.803% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.61 Million AUD | -170.577% |
| Micro-X Limited | 5.37 Million AUD | 18.611% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 391.67 Thousand AUD | -1017.758% |
| PolyNovo Limited | 8.97 Million AUD | 51.204% |
| Respiri Limited | 2.75 Million AUD | -59.107% |
| SomnoMed Limited | 6.28 Million AUD | 30.348% |
| Uscom Limited | 623.62 Thousand AUD | -602.013% |
| Visioneering Technologies, Inc. | 3.16 Million AUD | -38.236% |